Frankfurt - Delayed Quote EUR
Denali Therapeutics Inc. (4DN.F)
12.54
+0.18
+(1.42%)
At close: May 16 at 8:24:58 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-365,542
-347,694
-357,991
-244,716
-211,389
Investing Cash Flow
383,179
-88,756
249,308
-141,387
-21,626
Financing Cash Flow
-19,733
484,304
17,820
310,670
19,348
End Cash Position
60,053
176,535
128,681
219,544
294,977
Income Tax Paid Supplemental Data
--
0
3
47
210
Capital Expenditure
-18,840
-15,912
-12,939
-17,833
-8,500
Issuance of Capital Stock
0
499,253
0
296,215
0
Repayment of Debt
-36,695
-32,338
0
0
--
Free Cash Flow
-384,382
-363,606
-370,930
-262,549
-219,889
12/31/2021 - 3/23/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BH3.F PTC Therapeutics, Inc.
40.60
-0.98%
XP0.F Xenon Pharmaceuticals Inc.
26.20
-0.76%
WXXWY WuXi Biologics (Cayman) Inc.
6.00
+0.17%
VIGL Vigil Neuroscience, Inc.
2.4900
+7.33%
COCP Cocrystal Pharma, Inc.
1.4200
-1.73%
2269.HK WuXi Biologics (Cayman) Inc.
23.550
-1.26%
CRNX Crinetics Pharmaceuticals, Inc.
31.24
+0.10%
FOLD Amicus Therapeutics, Inc.
6.43
+8.07%
ANNX Annexon, Inc.
2.0100
+11.05%
URGN UroGen Pharma Ltd.
7.31
-25.79%